CA2
protein-codingcarbonic anhydrase 2, the group of Carbonic anhydrases
Gene summary
The protein encoded by this gene is one of several isozymes of carbonic anhydrase, which catalyzes reversible hydration of carbon dioxide. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009818
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009818
Submitter: ClinGen
*CA2* was first reported in relation to autosomal recessive osteopetrosis 3 in 1991 (Venta et al. 1991, PMID: 1928091). Osteopetrosis with renal tubular acidosis is a rare disorder characterized by osteopetrosis (OPT), renal tubular acidosis (RTA), and neurological disorders related to cerebral calcifications. It is also known as Carbonic anhydrase 2 deficiency, Guibaud-Vainsel syndrome, Marble brain disease, Mixed RTA, and RTA type 3. Eleven unique variants (missense, nonsense, frameshift, splice-site) that have been reported in 8 probands in 8 publications (PMIDs: 1928091, 1542674, 7627193, 19556665, 27848944, 33555497, 28509178, 37662627) are included in this curation. Variants in this gene segregated in 4 additional family members (PMIDs: 1542674, 28509178). More proband is reported in the literature but the maximum score for genetic evidence (12 pts) has been reached. This gene-disease relationship is supported by biochemical function study, expression data, and a mouse model replicating the phenotype (PMIDs: 8200964, 6405388, 16396925, 3126501, 18175028). In summary, there is definitive evidence to support the relationship between *CA2* and autosomal recessive osteopetrosis 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date June 10th, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0009818
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009818
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009818
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: Musculoskeletal; Renal
Rationale: Identification and treatment of renal tubular acidosis may be beneficial; Awareness of multi-organ system complications of osteopetrosis may allow surveillance and prompt management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000067.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 33 | 36 | |||
| missense | 3 | 1 | 77 | 3 | 1 | 85 |
| nonsense | 3 | 4 | 1 | 8 | ||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 4 | 1 | 7 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 3 | 8 | ||
| Total | 10 | 13 | 85 | 36 | 1 | 145 |
Highest pathogenic variant AF is 0.000018592038
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000058.1 | 7 | MANE Select | |
| Ensembl | ENSP00000285379.4 | 7 | MANE Select | |
| RefSeq | NP_001280604.1 | 5 | Standard | |
| Ensembl | ENSP00000428443.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cahz | Danio rerio | Structure: respiratory gaseous exchange Quality: process quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Bile secretion - Homo sapiens (human)
- Gastric acid secretion - Homo sapiens (human)
- Proximal tubule bicarbonate reclamation - Homo sapiens (human)
- Collecting duct acid secretion - Homo sapiens (human)
- Pancreatic secretion - Homo sapiens (human)
Biological Process
- kidney development
- morphogenesis of an epithelium
- response to pH
- response to zinc ion
- carbon dioxide transport
Molecular Function
- arylesterase activity
- carbonate dehydratase activity
- protein binding
- zinc ion binding
Cellular Component
- cytoplasm
- cytosol
- plasma membrane
- microvillus
- basolateral plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000285379
- Coding exons
- 7
- Length
- 17642
- Individuals with no LoFs
- 125729
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 19
- Defined
- 125748
- p
- 0.0000756
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.359 | 128 | 140 | 0.914 | 0.00000751 | 1709 |
| Missense (PolyPhen) | 42 | 57.159 | 0.73479 | 713 | ||
| Synonymous | 0.434 | 49 | 53.0 | 0.924 | 0.00000299 | 488 |
| Loss of Function | 0.615 | 10 | 12.3 | 0.811 | 5.26e-7 | 153 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000053 | 0.000053 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6. {ECO:0000250, ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:11831900, ECO:0000269|PubMed:15990874}.;
- Disease
- DISEASE: Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB3 is associated with renal tubular acidosis, cerebral calcification (marble brain disease) and in some cases with mental retardation. {ECO:0000269|PubMed:15300855, ECO:0000269|PubMed:1542674, ECO:0000269|PubMed:1928091, ECO:0000269|PubMed:8834238, ECO:0000269|PubMed:9143915}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.372
Intolerance Scores
- LoFtool
- 0.466
- RVIS EVS
- -0.14
- RVIS percentile EVS
- 43.29
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.913
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |